Development of in silico methodology for siRNA lipid nanoparticle formulations
Small interfering RNA (siRNA) gene silencing therapy has great potential for treating
multiple diseases. The lipid nanoparticle (LNP) technology for siRNA delivery succussed in …
multiple diseases. The lipid nanoparticle (LNP) technology for siRNA delivery succussed in …
[HTML][HTML] LINC01559 promotes lung adenocarcinoma metastasis by disrupting the ubiquitination of vimentin
H Feng, D Xu, C Jiang, Y Chen, J Wang, Z Ren, X Li… - Biomarker …, 2024 - Springer
Background Distant metastasis is the major cause of lung adenocarcinoma (LUAD)-
associated mortality. However, molecular mechanisms involved in LUAD metastasis remain …
associated mortality. However, molecular mechanisms involved in LUAD metastasis remain …
Integrated in Silico Formulation Design of Lipid-based Drug Delivery Systems
H Gao - 2022 - search.proquest.com
Lipid-based drug delivery system (LBDDS) has shown great potential in pharmaceutical
formulation. LBDDS is a dosage form with lipid as the main excipient, which increases the …
formulation. LBDDS is a dosage form with lipid as the main excipient, which increases the …
[PDF][PDF] Long Non-coding RNA LINC02679 Regulates TRIML2 Expression to Promote the Proliferation and Invasion of Gastric Cancer Cells by Targeting miR-5004-3p
B Tan, Y Li, Z Chen, Q Zhao, M Tan, Y Zhao, Y Xia… - 2022 - scholar.archive.org
Long non-coding RNAs (lncRNAs) play a key role in regulating the development, invasion
and metastasis of gastric cancer. However, the speci c clinical value and mechanism of …
and metastasis of gastric cancer. However, the speci c clinical value and mechanism of …